Insulet (PODD) News Mentions Statistics 2024

0 100%

1W 0% 1M 0% 3M 0%

Est. daily news mentions.

Similar companies

Company		News Mentions
	Boston Scientific BSX	0 0%
	Edwards Lifesciences EW	0 0%
	Intuitive Surgical ISRG	0 0%
	Medtronic MDT	0 0%
	Stryker SYK	1 0%

Insulet (PODD) – Investment Analysts’ Weekly Ratings Changes

December 25

Insulet Corp. stock outperforms competitors despite losses on the day

December 24

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of “Moderate Buy” from Analysts

December 23

Canaccord Genuity Group Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock

December 10

Should You Continue to Retain Insulet Stock in Your Portfolio Now?

December 8

Month over Month

Est. daily news mentions.

Nov 2024	0	50.8%
Oct 2024	1	190.3%
Sep 2024	0	34.2%
Aug 2024	0
Jul 2024	0	0%

How often is Insulet mentioned in the news?

Insulet was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Insulet performing compared to its industry peers?

Insulet underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Insulet in the last month?

There has been no significant change in the number of news mentions for Insulet's compared to the last month.

Why is it important to track news mentions for Insulet?

By monitoring mentions in the news for Insulet, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Insulet, ultimately improving their investment strategies.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Insulet (PODD) - News Mentions

Similar companies

Boston Scientific

Edwards Lifesciences

Intuitive Surgical

Medtronic

Stryker

Insulet (PODD) – Investment Analysts’ Weekly Ratings Changes

Insulet Corp. stock outperforms competitors despite losses on the day

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of “Moderate Buy” from Analysts

Stifel Financial Corp Has $2.45 Million Position in Insulet Co. (NASDAQ:PODD)

Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry

Insulet Co. (NASDAQ:PODD) Position Reduced by HighTower Advisors LLC

Insulet (NASDAQ:PODD) Price Target Raised to $330.00

Captrust Financial Advisors Purchases 86 Shares of Insulet Co. (NASDAQ:PODD)

Insulet (NASDAQ:PODD) Hits New 52-Week High After Analyst Upgrade

Janus Henderson Group PLC Raises Stock Position in Insulet Co. (NASDAQ:PODD)

Citigroup Increases Insulet (NASDAQ:PODD) Price Target to $310.00

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

RMD or PODD: Which Is the Better Value Stock Right Now?

Insulet price target raised by $27 at Citi, here's why